TY - JOUR
T1 - Catalytic properties of CYP1A isoforms in the liver of an agnathan (Lampetra fluviatilis) and two species of teleost (Pleuronectes flesus, Anguilla anguilla)
AU - Rotchell, J M
AU - Steventon, G B
AU - Bird, D J
PY - 2000/2
Y1 - 2000/2
N2 - The catalytic activity of CYP1A isoforms and the effect of mammalian CYP1A-specific inhibitors in liver S9 fractions were studied in an agnathan (River lamprey, Lampetra fluviatilis, 30-33 cm) and in two species of teleost fish (European flounder. Pleuronectes flesus, 11-18 cm and common eel, Anguilla anguilla, 31-45 cm). Ethoxyresorufin O-deethylation (EROD), caffeine N-demethylation/C-oxidation and phenacetin O-deethylation (POD) activity increased 3-4-fold in flounders and 17-46-fold in eels, 5 days after fish were injected (i.p.) with 100 mg kg(-1) benzo(a)pyrene (B[a]P). In lampreys, basal EROD activity was very low and no increase in activity was observed following exposure to B[a]P. While the apparent Michaelis constant (K-m) for each assay showed only small changes after B[a]P injection, maximum-reaction velocity (V-max) values increased by up to 19- acid 84-fold for EROD activity, 4- and 35-fold for caffeine-related metabolism and 4- and 19-fold for POD activity in flounders and eels, respectively. The mammalian CYP1A2 inhibitor furafylline (50 mu M-1 mM) reduced activity in the EROD, caffeine and POD assays to 65, 21 and 20% of control values in flounders and to 85, 10 and 5% of control values in eels, respectively. By contrast, low concentrations (0.025-0.050 mu M) of the mammalian CYP1A1 inhibitor ellipticine completely abolished EROD activity, but had no effect (up to 1 mM) on caffeine metabolism or POD activity in either species. While the inhibitor studies strongly suggest that two separate enzymes are present in flounders and eels, the monophasic Michaelis-Menten kinetics obtained in all the assays imply that only a single CYP1A protein is present that has substrate and inhibitor specificities characteristic bf both mammalian CYP1A1 and CYP1A2 isoforms. (C) 2000 Elsevier Science Inc. All rights reserved.
AB - The catalytic activity of CYP1A isoforms and the effect of mammalian CYP1A-specific inhibitors in liver S9 fractions were studied in an agnathan (River lamprey, Lampetra fluviatilis, 30-33 cm) and in two species of teleost fish (European flounder. Pleuronectes flesus, 11-18 cm and common eel, Anguilla anguilla, 31-45 cm). Ethoxyresorufin O-deethylation (EROD), caffeine N-demethylation/C-oxidation and phenacetin O-deethylation (POD) activity increased 3-4-fold in flounders and 17-46-fold in eels, 5 days after fish were injected (i.p.) with 100 mg kg(-1) benzo(a)pyrene (B[a]P). In lampreys, basal EROD activity was very low and no increase in activity was observed following exposure to B[a]P. While the apparent Michaelis constant (K-m) for each assay showed only small changes after B[a]P injection, maximum-reaction velocity (V-max) values increased by up to 19- acid 84-fold for EROD activity, 4- and 35-fold for caffeine-related metabolism and 4- and 19-fold for POD activity in flounders and eels, respectively. The mammalian CYP1A2 inhibitor furafylline (50 mu M-1 mM) reduced activity in the EROD, caffeine and POD assays to 65, 21 and 20% of control values in flounders and to 85, 10 and 5% of control values in eels, respectively. By contrast, low concentrations (0.025-0.050 mu M) of the mammalian CYP1A1 inhibitor ellipticine completely abolished EROD activity, but had no effect (up to 1 mM) on caffeine metabolism or POD activity in either species. While the inhibitor studies strongly suggest that two separate enzymes are present in flounders and eels, the monophasic Michaelis-Menten kinetics obtained in all the assays imply that only a single CYP1A protein is present that has substrate and inhibitor specificities characteristic bf both mammalian CYP1A1 and CYP1A2 isoforms. (C) 2000 Elsevier Science Inc. All rights reserved.
UR - http://www.scopus.com/inward/record.url?scp=0034062479&partnerID=8YFLogxK
U2 - 10.1016/S0742-8413(99)00105-X
DO - 10.1016/S0742-8413(99)00105-X
M3 - Article
VL - 125
SP - 203
EP - 214
JO - Comparative Biochemistry and Physiology. Part C: Pharmacology, Toxicology & Endocrinology
JF - Comparative Biochemistry and Physiology. Part C: Pharmacology, Toxicology & Endocrinology
IS - 2
ER -